- Home
- CHX vs IMVT Comparison
CHX vs IMVT Comparison
Compare CHX & IMVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHX
- IMVT
- Stock Information
- Founded
- CHX 1882
- IMVT N/A
- Country
- CHX United States
- IMVT United States
- Employees
- CHX N/A
- IMVT N/A
- Industry
- CHX Industrial Machinery/Components
- IMVT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CHX Industrials
- IMVT Health Care
- Exchange
- CHX Nasdaq
- IMVT Nasdaq
- Market Cap
- CHX 5.2B
- IMVT 4.2B
- IPO Year
- CHX N/A
- IMVT N/A
- Fundamental
- Price
- CHX $25.79
- IMVT $25.86
- Analyst Decision
- CHX Buy
- IMVT Strong Buy
- Analyst Count
- CHX 4
- IMVT 11
- Target Price
- CHX $39.00
- IMVT $47.60
- AVG Volume (30 Days)
- CHX 1.9M
- IMVT 952.1K
- Earning Date
- CHX 02-03-2025
- IMVT 02-10-2025
- Dividend Yield
- CHX 1.47%
- IMVT N/A
- EPS Growth
- CHX 7.15
- IMVT N/A
- EPS
- CHX 1.62
- IMVT N/A
- Revenue
- CHX $3,665,501,000.00
- IMVT N/A
- Revenue This Year
- CHX N/A
- IMVT N/A
- Revenue Next Year
- CHX $3.98
- IMVT N/A
- P/E Ratio
- CHX $15.92
- IMVT N/A
- Revenue Growth
- CHX N/A
- IMVT N/A
- 52 Week Low
- CHX $25.46
- IMVT $24.61
- 52 Week High
- CHX $39.95
- IMVT $45.58
- Technical
- Relative Strength Index (RSI)
- CHX 22.21
- IMVT 38.95
- Support Level
- CHX $28.66
- IMVT $26.19
- Resistance Level
- CHX $29.69
- IMVT $28.08
- Average True Range (ATR)
- CHX 0.78
- IMVT 1.12
- MACD
- CHX -0.43
- IMVT -0.22
- Stochastic Oscillator
- CHX 5.55
- IMVT 14.39
About CHX ChampionX Corporation
ChampionX provides chemical solutions and equipment for onshore and offshore oil and gas production. Its engineering expertise spans the well lifecycle, but the firm maintains a particular focus on the production phase. Key offerings include artificial lift services and drilling technologies, specializing in polycrystalline diamond cutter inserts. ChampionX was formed after Apergy acquired its chemical technologies business from Ecolab in 2020.
About IMVT Immunovant Inc.
Immunovant Inc is a clinical-stage biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The company's product includes batoclimab and IMVT-1402 targets the neonatal Fc receptor (FcRn).